Harmony Biosciences Inc.

NASDAQ: HRMY · Real-Time Price · USD
36.88
0.37 (1.01%)
At close: Aug 15, 2025, 3:59 PM
36.87
-0.03%
After-hours: Aug 15, 2025, 04:10 PM EDT

Harmony Biosciences Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
180.9M 152.72M 145.49M 122.63M 114.99M 137.7M 128.85M 150.75M 200.24M 189.47M 181.47M 155.67M 58.11M 48.7M 34.6M 11.68M 23.21M 9.06M
Depreciation & Amortization
23.87M 23.96M 24.11M 24.27M 24.41M 24.42M 24.36M 24.3M 24.26M 24.25M 23.39M 22.08M 20.69M 19.36M 18.84M 18.46M 15.76M 13.03M
Stock-Based Compensation
45.07M 44.71M 42.6M 41.39M 38.34M 34.9M 31.7M 30.1M 29.12M 28.75M 26.17M 23.11M 20.36M 16.99M 15.66M 14.28M 11.1M 7.63M
Other Working Capital
30.43M 13M 8.79M 26.97M 13.94M 36.14M 46.55M -11.72M 14.84M 17.59M 12.87M 48.24M 15.06M 12.75M 15.46M 19.47M 11.46M 14.79M
Other Non-Cash Items
4.35M 38.69M 95.81M 97.17M 107.37M 44.74M 12.85M 11.66M 1.36M 1.93M 3.49M 2.98M 3.41M 3.13M 2.68M 5.57M 5.32M 5.08M
Deferred Income Tax
-22.34M -30.13M -29.3M -21.46M -23.54M -13.45M -13.42M -18.81M -93.58M -89.39M -85.94M -81.68M 26.15M 26.15M 26.15M 26.15M 1.52M 1.96M
Change in Working Capital
27.52M 13.01M -7.32M 8.51M 3.53M 10.97M 35.03M -28.61M 104K 3.16M -4.11M 33.16M 1.83M 556K 631K -5.07M -7.43M -513K
Operating Cash Flow
259.38M 222.67M 219.82M 220.92M 213.52M 207.97M 219.39M 169.4M 161.5M 158.17M 144.47M 155.32M 130.54M 114.88M 98.56M 71.07M 49.48M 36.25M
Capital Expenditures
-648K -1.28M -1.15M -747K -744K -317K -312K 39.97M 39.88M 40.05M n/a 60.13M 60.12M 59.96M n/a -102.3M -102.2M -102.01M
Cash Acquisitions
n/a -33.07M -33.07M -77.6M -77.6M -36.97M -36.97M 7.57M 6.69M -872K -872K -100.87M -100M -100M -100M n/a n/a n/a
Purchase of Investments
-102M -99.31M -105.29M -91.22M -100.94M -104.8M -127.47M -160.95M -161.17M -158.5M -110.73M -55.64M -22.41M n/a n/a n/a n/a n/a
Sales Maturities Of Investments
94.98M 101.22M 98.53M 91.14M 99.3M 91.25M 118.31M 103.88M 72.56M 55.05M 9.07M 872K n/a n/a n/a n/a n/a n/a
Other Investing Acitivies
-16M -26.5M -32.68M -24.11M -24.93M -6.99M -2.6M -50.34M -48.66M -63.5M -101.71M 38.47M 37.59M 60M n/a -102M -102M -102M
Investing Cash Flow
-23.67M -58.94M -67.48M -96.36M -97.92M -50.84M -46.44M -57.27M -88.9M -103.58M -141.83M 5.36M 37.71M 59.96M n/a -102.3M -102.2M -102.01M
Debt Repayment
-11.25M -15M -15M -15M 188.75M 192M 195.25M 198.5M -2M -2M -2M -2M -23.5M -23M -22.5M -22M n/a n/a
Common Stock Repurchased
269K n/a n/a -50M -100.27M -100.51M -100.51M -50.51M -514K n/a n/a n/a n/a n/a n/a -167K -167K -334K
Dividend Paid
n/a n/a n/a -55.26M -55.26M -55.26M -55.26M n/a n/a n/a n/a n/a n/a n/a n/a -44.91M -44.91M -44.91M
Other Financial Acitivies
4.3M 3.54M 4M 58.48M -199.19M -199.34M -195.54M -247.87M 9.78M 10.87M 8.84M 13.26M 32.39M 31.79M 29.92M 21.19M -11.5M -12.15M
Financial Cash Flow
-6.95M -7.71M -11M -61.78M -115.7M -112.59M -105.55M -49.37M 7.78M 8.87M 6.84M 11.26M 8.89M 8.79M 7.42M -809K 136.13M 135.41M
Net Cash Flow
229.02M 156.29M 141.61M 63.05M -99K 44.54M 67.4M 62.76M 80.38M 63.46M 9.47M 71.64M 76.85M 83.33M 5.68M -32.04M 83.41M 69.65M
Free Cash Flow
258.73M 221.39M 218.67M 220.18M 212.78M 207.65M 219.07M 209.37M 201.39M 198.22M 144.47M 215.45M 190.66M 174.84M 98.56M -31.23M -52.72M -65.76M